1997
DOI: 10.1016/s0192-0561(97)00054-4
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial cell wall components as immunomodulators—I. lipopeptides as adjuvants for parenteral and oral immunization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0
1

Year Published

2002
2002
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(27 citation statements)
references
References 10 publications
1
25
0
1
Order By: Relevance
“…They have long been known as strong cytokine inducers and have recently become the basis for vaccine development, making them key molecules of innate and adaptive immunity (16,55). We show in this study that a host acute-phase protein, LBP, which previously has been known to be a key molecule for pathogen recognition via LPS, LTA, and peptidoglycan, is also crucial for lipoprotein recognition.…”
Section: Discussionmentioning
confidence: 72%
“…They have long been known as strong cytokine inducers and have recently become the basis for vaccine development, making them key molecules of innate and adaptive immunity (16,55). We show in this study that a host acute-phase protein, LBP, which previously has been known to be a key molecule for pathogen recognition via LPS, LTA, and peptidoglycan, is also crucial for lipoprotein recognition.…”
Section: Discussionmentioning
confidence: 72%
“…In addition to LPS a dramatically higher response with respect to TNF was seen with Pam3Cys, a product of Borrelia and of other types of bacteria (12)(13)(14)(15)(16). Also, Zymosan derived from yeast and mycobacterial lipoarabinomannan both induced 2-fold higher levels of specific median immunofluorescence intensity for TNF in the proinflammatory monocytes (data not shown).…”
Section: Cd16mentioning
confidence: 99%
“…The contribution is more pronounced when it comes to Pam3Cys, a compound that represents lipopeptides that are expressed by both Gram-positive and Gram-negative bacteria (12)(13)(14)(15)(16). Hence, lipopeptide-induced cytokines may contribute to any type of bacterial infection.…”
Section: Drmentioning
confidence: 99%
“…Lipopolysaccharide from pathogenic enterobacterial bacteria (eLPS) has been applied in numerous experimental models of infection in which PRRs such as LPS-binding protein (LBP) and CD14 have central roles (2)(3)(4). Lipoprotein is an immunostimulatory PAMP as well (5)(6)(7). Challenge with immunostimulatory Gram-negative or Gram-positive bacterial constituents overactivates the immune system and elicits symptoms that in part are characteristic for sepsis in the course of acute infection (8).…”
mentioning
confidence: 99%